Abstract
CRISPR/Cas9 genome-editing system is a powerful, fairly accurate, and efficient tool for modifying genomic DNA. Despite obvious advantages, it is not devoid of certain drawbacks, such as propensity for introduction of additional nonspecific DNA breaks, insufficient activity against aneuploid genomes, and relative difficulty in delivering its components to cells. In this review, we focus on the difficulties that can limit the use of CRISPR/Cas9 and suggest a number of practical recommendations and information sources that will make it easier for the beginners to work with this outstanding technological achievement of the XXI century.
Similar content being viewed by others
References
Mojica, F. J. M., Diez-Villasenor, C., Garcia-Martinez, J., and Soria, E. (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic ele-ments, J. Mol. Evol., 60, 174–182.
Sorek, R., Kunin, V., and Hugenholtz, P. (2008) CRISPR–a widespread system that provides acquired resistance against phages in bacteria and archaea, Nat. Rev. Microbiol., 6, 181–186.
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., and Doudna, J. (2013) RNA-programmed genome editing in human cells, Elife, 2, e00471.
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., and Zhang, F. (2013) Genome engineering using the CRISPR–Cas9 system, Nat. Protoc., 8, 2281–2308.
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., and Church, G. M. (2013) RNA-guided human genome engineering via Cas9, Science, 339, 823–826.
Gaj, T., Gersbach, C. A., and Barbas, C. F. (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering, Trends Biotech., 31, 397–405.
Marraffini, L. A. (2016) The CRISPR–Cas system of Streptococcus pyogenes: function and applications, in Streptococcus pyogenes Basic Biology to Clinical Manifestations (Ferretti, J. J., Stevens, D. L., and Fischetti, V. A., eds.) The University of Oklahoma Health Sciences Center, Oklahoma City, pp. 1–13 (https://www.ncbi.nlm. nih.gov/books/NBK355562/).
Mojica, F. J. M., Diez-Villasenor, C., Garcia-Martinez, J., and Almendros, C. (2009) Short motif sequences deter-mine the targets of the prokaryotic CRISPR defence sys-tem, Microbiology, 155, 733–740.
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., and Doudna, J. A. (2014) DNA interrogation by the CRISPR RNA-guided endonuclease Cas9, Nature, 507, 62–67.
Betermier, M., Bertrand, P., and Lopez, B. S. (2014) Is non-homologous end-joining really an inherently error-prone process? PLoS Genetics, 10, e1004086.
Lieber, M. R. (2010) The mechanism of double-strand DNA break repair by the nonhomologous DNA end-join-ing pathway, Annu. Rev. Biochem., 79, 181–211.
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., and Charpentier, E. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, 337, 816–821.
Ran, F. A., Hsu, P. D., Lin, C. Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., and Zhang, F. (2013) Double nick-ing by RNA-guided CRISPR–Cas9 for enhanced genome editing specificity, Cell, 154, 1380–1389.
Tsai, S. Q., Wyvekens, N., Khayter, C., Foden, J. A., Thapar, V., Reyon, D., Goodwin, M. J., Aryee, M. J., and Joung, J. K. (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing, Nat. Biotechnol., 32, 569–576.
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., and Zhang, F. (2016) Rationally engineered Cas9 nucleases with improved specificity, Science, 351, 84–88.
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., and Joung, J. K. (2016) High-fidelity CRISPR–Cas9 nucleases with no detect-able genome-wide off-target effects, Nature, 529, 490–495.
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., Van Der Oost, J., Regev, A., Koonin, E. V., and Zhang, F. (2015) Cpf1 is a single RNA-guided endonu-clease of a class 2 CRISPR–Cas system, Cell, 163, 759–771.
Kim, D., Kim, J., Hur, J. K., Been, K. W., Yoon, S. H., and Kim, J. S. (2016) Genome-wide analysis reveals specifici-ties of Cpf1 endonucleases in human cells, Nat. Biotechnol., 34, 863–868.
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., Cradick, T. J., Marraffini, L. A., Bao, G., and Zhang, F. (2013) DNA targeting specificity of RNA-guided Cas9 nucleases, Nat. Biotechnol., 31, 827–832.
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., Aryee, M. J., and Joung, J. K. (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR–Cas nucleases, Nat. Biotechnol., 33, 187–198.
Zetsche, B., Heidenreich, M., Mohanraju, P., Fedorova, I., Kneppers, J., Degennaro, E. M., Winblad, N., Choudhury, S. R., Abudayyeh, O. O., Gootenberg, J. S., Wu, W. Y., Scott, D. A., Severinov, K., van Der Oost, J., and Zhang, F. (2017) Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array, Nature Biotech., 35, 31–34.
Suzuki, K., and ·Izpisua Belmonte, J. (2017) In vivo genome editing via the HITI method as a tool for gene therapy, J. Hum. Genet., 63, 157–164.
Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., Wu, J., Zhu, J., Kim, E. J., Hatanaka, F., Yamamoto, M., Araoka, T., Li, Z., Kurita, M., Hishida, T., Li, M., Aizawa, E., Guo, S., Chen, S., Goebl, A., Soligalla, R. D., Qu, J., Jiang, T., Fu, X., Jafari, M., Esteban, C. R., Berggren, W. T., Lajara, J., Nunez-Delicado, E., Guillen, P., Campistol, J. M., Matsuzaki, F., Liu, G. H., Magistretti, P., Zhang, K., Callaway, E. M., Zhang, K., and Belmonte, J. C. I. (2016) In vivo genome editing via CRISPR/Cas9 mediated homol-ogy-independent targeted integration, Nature, 540, 144–149.
Chew, W. L., Tabebordbar, M., Cheng, J. K. W., Mali, P., Wu, E. Y., Ng, A. H. M., Zhu, K., Wagers, A. J., and Church, G. M. (2016) A multifunctional AAV-CRISPR-Cas9 and its host response, Nat. Methods, 13, 868–874.
Ortinski, P. I., O’Donovan, B., Dong, X., and Kantor, B. (2017) Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR/Cas9-mediated gene editing, Mol. Ther. Methods Clin. Dev., 5, 153–164.
Hindriksen, S., Bramer, A. J., Truong, M. A., Vromans, M. J. M., Post, J. B., Verlaan-Klink, I., Snippert, H. J., Lens, S. M. A., and Hadders, M. A. (2017) Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells, PLoS One, 12, e0179514.
Addgene.org http://addgene.org
Mao, Z., Bozzella, M., Seluanov, A., and Gorbunova, V. (2008) Comparison of nonhomologous end joining and homologous recombination in human cells, DNA Repair (Amst)., 7, 1765–1771.
Kouranova, E., Forbes, K., Zhao, G., Warren, J., Bartels, A., Wu, Y., and Cui, X. (2016) CRISPRs for optimal tar-geting: delivery of CRISPR components as DNA, RNA, and protein into cultured cells and single-cell embryos, Hum. Gene Ther., 27, 464–475.
Lee, M. T., Bonneau, A. R., and Giraldez, A. J. (2014) Zygotic genome activation during the maternal-to-zygotic transition, Annu. Rev. Cell Dev. Biol., 30, 581–613.
Sato, M., Koriyama, M., Watanabe, S., Ohtsuka, M., Sakurai, T., Inada, E., Saitoh, I., Nakamura, S., and Miyoshi, K. (2015) Direct injection of CRISPR/Cas9-related mRNA into cytoplasm of parthenogenetically acti-vated porcine oocytes causes frequent mosaicism for indel mutations, Int. J. Mol. Sci., 16, 17838–17856.
D’Astolfo, D. S., Pagliero, R. J., Pras, A., Karthaus, W. R., Clevers, H., Prasad, V., Lebbink, R. J., Rehmann, H., and Geijsen, N. (2015) Efficient intracellular delivery of native proteins, Cell, 161, 674–690.
Liu, C., Zhang, L., Liu, H., and Cheng, K. (2017) Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications, J. Contr. Rel., 266, 17–26.
He, Z. Y., Men, K., Qin, Z., Yang, Y., Xu, T., and Wei, Y. Q. (2017) Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field, Sci. China Life Sci., 60, 458–467.
Wang, L., Li, F., Dang, L., Liang, C., Wang, C., He, B., Liu, J., Li, D., Wu, X., Xu, X., Lu, A., and Zhang, G. (2016) In vivo delivery systems for therapeutic genome edit-ing, Int. J. Mol. Sci., 17, 626.
GENScript gRNA Database (https://www.genscript.com/gRNA-database.html).
Park, J., Kim, J. S., and Bae, S. (2016) Cas-database: Web-based genome-wide guide RNA library design for gene knockout screens using CRISPR-Cas9, Bioinformatics, 32, 2017–2023.
Park, J., Bae, S., and Kim, J. S. (2015) Cas-designer: a web-based tool for choice of CRISPR-Cas9 target sites, Bioinformatics, 31, 4014–4016.
Optimized CRISPR Design (http://crispr.mit.edu/).
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., Virgin, H. W., Listgarten, J., and Root, D. E. (2016) Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9, Nat. Biotechnol., 34, 184–191.
Stemmer, M., Thumberger, T., Del Sol Keyer, M., Wittbrodt, J., and Mateo, J. L. (2015) CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool, PLoS One, 10, e0124633.
Benchling (https://benchling.com).
Labun, K., Montague, T. G., Gagnon, J. A., Thyme, S. B., and Valen, E. (2016) CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering, Nuceic Acids Res., 44, 272–276.
Sander, J. D., Maeder, M. L., Reyon, D., Voytas, D. F., Joung, J. K., and Dobbs, D. (2010) ZiFiT (zinc finger tar-geter): an updated zinc finger engineering tool, Nucleic Acids Res., 38, 462–468.
Bae, S., Park, J., and Kim, J. S. (2014) Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics, 30, 1473–1475.
Cradick, T. J., Qiu, P., Lee, C. M., Fine, E. J., and Bao, G. (2014) COSMID: a web-based tool for identifying and val-idating CRISPR/Cas off-target sites, Mol. Ther. Nucleic Acids, 3, e214.
Ensembl Genome Browser (http://www.ensembl.org/index. html).
Database (https://www.ncbi.nlm.nih.gov/nuccore/).
Bazykin, G. A., and Kochetov, A. V. (2011) Alternative translation start sites are conserved in eukaryotic genomes, Nucleic Acids Res., 39, 567–577.
Lin, Y., Cradick, T. J., Brown, M. T., Deshmukh, H., Ranjan, P., Sarode, N., Wile, B. M., Vertino, P. M., Stewart, F. J., and Bao, G. (2014) CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences, Nucleic Acids Res., 42, 7473–7485.
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Kaini, P., Sander, J. D., Joung, J. K., Peterson, R. T., and Yeh, J. R. J. (2013) Heritable and precise zebrafish genome editing using a CRISPR-Cas system, PLoS One, 8, e68708.
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., and Joung, J. K. (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs, Nat. Biotechnol., 32, 279–284.
Liu, X., Homma, A., Sayadi, J., Yang, S., Ohashi, J., and Takumi, T. (2016) Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system, Sci. Rep., 6, 19675.
Wang, T., Wei, J. J., Sabatini, D. M., and Lander, E. S. (2014) Genetic screens in human cells using the CRISPR-Cas9 system, Science, 343, 80–84.
Thyme, S. B., Akhmetova, L., Montague, T. G., Valen, E., and Schier, A. F. (2016) Internal guide RNA interactions interfere with Cas9-mediated cleavage, Nat. Commun., 7, 11750.
Doench, J. G., Hartenian, E., Graham, D. B., Tothova, Z., Hegde, M., Smith, I., Sullender, M., Ebert, B. L., Xavier, R. J., and Root, D. E. (2014) Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactiva-tion, Nat. Biotechnol., 32, 1262–1267.
Bae, S., Kweon, J., Kim, H. S., and Kim, J. S. (2014) Microhomology-based choice of Cas9 nuclease target sites, Nature Methods, 11, 705–706.
Van Overbeek, M., Capurso, D., Carter, M. M., Thompson, M. S., Frias, E., Russ, C., Reece-Hoyes, J. S., Nye, C., Gradia, S., Vidal, B., Zheng, J., Hoffman, G. R., Fuller, C. K., and May, A. P. (2016) DNA repair profiling reveals nonrandom outcomes at Cas9-mediated breaks, Mol. Cell, 63, 633–646.
Chen, X., Rinsma, M., Janssen, J. M., Liu, J., Maggio, I., and Gonзalves, M. A. F. V. (2016) Probing the impact of chromatin conformation on genome editing tools, Nucleic Acids Res., 44, 6482–6492.
Xie, K., Minkenberg, B., and Yang, Y. (2015) Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system, Proc. Natl. Acad. Sci. USA, 112, 3570–3575.
Wang, J., Chen, R., Zhang, R., Ding, S., Zhang, T., Yuan, Q., Guan, G., Chen, X., Zhang, T., Zhuang, H., Nunes, F., Block, T., Liu, S., Duan, Z., Xia, N., Xu, Z., and Lu, F. (2017) The gRNA-miRNA-gRNA ternary cassette com-bining CRISPR/Cas9 with RNAi approach strongly inhibits hepatitis B virus replication, Theranostics, 7, 3090–3105.
Cazenave, C., and Uhlenbeck, O. C. (1994) RNA tem-plate-directed RNA synthesis by T7 RNA polymerase, Proc. Natl. Acad. Sci. USA, 91, 6972–6976.
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., and Zhang, F. (2013) Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819–823.
AddGene CRISPR Protocols (https://www.addgene.org/crispr/reference/#protocols).
Renkawitz, J., Lademann, C. A., and Jentsch, S. (2014) Mechanisms and principles of homology search during recombination, Nat. Rev. Mol. Cell Biol., 15, 369–683.
Verma, P., and Greenberg, R. A. (2016) Noncanonical views of homology-directed DNA repair, Genes Devel., 30, 1138–1154.
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., and Jaenisch, R. (2013) One-step generation of mice carry-ing reporter and conditional alleles by CRISPR/Cas-medi-ated genome engineering, Cell, 154, 1370–1379.
Doudna, J. A., and Sontheimer, E. J. (2014) The use of CRISPR/Cas9, ZFNs, and TALENs in generating site-specific genome alterations, Methods Enzymol., 546, xix-xx; doi: 10.1016/B978-0-12-801185-0.09983-9.
GELife HDR Designer (http://dharmacon.gelifesciences.com/gene-editing/crispr-cas9/edit-r-hdr-donor-designer/).
Yang, D., Scavuzzo, M. A., Chmielowiec, J., Sharp, R., Bajic, A., and Borowiak, M. (2016) Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucle-ases, Sci. Rep., 6, 21264.
Chu, V. T., Weber, T., Wefers, B., Wurst, W., Sander, S., Rajewsky, K., and Kuhn, R. (2015) Increasing the efficien-cy of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells, Nat. Biotechnol., 33, 543–548.
Tyurin-Kuzmin, P. A., Karagyaur, M. N., Rubtsov, Y. P., Dyikanov, D. T., Vasiliev, P. A., and Vorotnikov, A. V. (2018) CRISPR/Cas9-mediated modification of the extreme C-terminus impairs PDGF-stimulated activity of Duox2, Biol. Chem., doi: 10.1515/hsz-2017-0229.
Vouillot, L., Thelie, A., and Pollet, N. (2015) Comparison of T7E1 and surveyor mismatch cleavage assays to detect mutations triggered by engineered nucleases, G3 (Bethesda), 5, 407–415.
Brinkman, E. K., Chen, T., Amendola, M., and Van Steensel, B. (2014) Easy quantitative assessment of genome editing by sequence trace decomposition, Nucleic Acids Res., 42, e168.
Truett, G. E., Heeger, P., Mynatt, R. L., Truett, A. A., Walker, J. A., and Warman, M. L. (2000) Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and Tris (HotSHOT), Biotechniques, 29, 52–54.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M. N. Karagyaur, Y. P. Rubtsov, P. A. Vasiliev, V. A. Tkachuk, 2018, published in Biokhimiya, 2018, Vol. 83, No. 6, pp. 800-815.
Rights and permissions
About this article
Cite this article
Karagyaur, M.N., Rubtsov, Y.P., Vasiliev, P.A. et al. Practical Recommendations for Improving Efficiency and Accuracy of the CRISPR/Cas9 Genome Editing System. Biochemistry Moscow 83, 629–642 (2018). https://doi.org/10.1134/S0006297918060020
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297918060020